Dr. Gleeson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5150 Journal Center Blvd NE
Albuquerque, NM 87109Phone+1 505-262-7455Fax+1 505-262-3955
Summary
- Dr. Jeremy Gleeson is an experienced Endocrinologist based in Albuquerque, NM, with subspecialties in Diabetes, Lipid Metabolism, Osteoporosis & Bone Metabolism Medicine, and Thyroid. He completed his education at the University of Auckland Faculty of Medicine and Health Sciences in 1978 and his fellowship in Endocrinology, Diabetes, and Metabolism at the University of Utah Health from 1984 - 1988. Dr. Gleeson is recognized for his multiple publications in Managed Care, Journal of Managed Care Pharmacy, Diabetes Care, Disease Management, and Atherosclerosis with one of his works cited 89 times. Over the course of his career, he has been awarded as a Regional Top Doctor from Castle Connolly in 2014 and became a Fellow of the American College of Physicians in 2000 and of the American Association of Clinical Endocrinology.
Education & Training
- University of Utah HealthFellowship, Endocrinology, Diabetes, and Metabolism, 1984 - 1988
- University of Auckland Faculty of Medicine and Health SciencesClass of 1978
Certifications & Licensure
- NM State Medical License 1989 - 2026
- UT State Medical License 1985 - 1990
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Fellow (FACP) American College of Physicians, 2000
- Fellow (FACE) American Association of Clinical Endocrinology
Publications & Presentations
PubMed
- Protocols and working with oncologists.Jeremy M Gleeson
Managed Care. 2007-03-01 - 1 citationsIncretin mimetics: promising new therapeutic options in the treatment of type 2 diabetes.Jeremy M Gleeson, David M Berenbeim, Robert J Gilkin
Journal of Managed Care Pharmacy. 2005-09-01 - 89 citationsAdequacy of Glycemic, Lipid, and Blood Pressure Management for Patients With Diabetes in a Managed Care SettingSarah J. Beaton, Soma S. Nag, Margaret J. Gunter, Jeremy M. Gleeson, Shiva S. Sajjan
Diabetes Care. 2004-03-01
Press Mentions
- Comparative Effectiveness of Patient Education Methods for Type 2 DiabetesA Randomized Controlled TrialDecember 12th, 2011
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: